“Moving forward, cancer may not be a death threat but a manageable disease with strong control”

Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...

October 31, 2024 | Thursday | Opinion
Digital Innovations in Diabetes Care

Diabetes affects 1 in 11 adults, or about 90 million people, in South-East Asia, with this number projected to rise to 1...

October 31, 2024 | Thursday | Analysis
Merck invests $76 M to expand ADC manufacturing for novel cancer therapies

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...

October 30, 2024 | Wednesday | News
Seaport Therapeutics secures $225 M funding to develop neuropsychiatric medicines using prodrug technology

The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...

October 26, 2024 | Saturday | News
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment

HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...

October 22, 2024 | Tuesday | News
Isolere Bio by Donaldson Launches Research-Grade IsoTag™ AAV Reagent for Rapid, Non-Chromatographic Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...

October 18, 2024 | Friday | News
Singapore discovers novel gene therapy offering hope for epilepsy patients

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working on a t...

October 15, 2024 | Tuesday | News
Caring Cross Champions Healthcare Equity: Dr. Boro Dropulić on Reshaping CAR-T Cell Therapies Through Decentralized Manufacturing

In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...

October 14, 2024 | Monday | News
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...

October 13, 2024 | Sunday | News
National University of Singapore and Imperial College London establish major research partnership

National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen resear...

October 13, 2024 | Sunday | News
Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

October 11, 2024 | Friday | News
$18 M investment for world-first Australian research project for heart attack protection

The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...

October 7, 2024 | Monday | News
Singapore strategises advance modalities for cancer- and age-related muscle degeneration

The global population is aging rapidly, and sarcopenia, a condition that severely diminishes quality of life in older ad...

September 26, 2024 | Thursday | News
Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing

Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...

September 24, 2024 | Tuesday | News
Antibody Engineering & Therapeutics Asia 2024: A Premier Gathering for Cutting-Edge Antibody Research and Innovation

Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...

September 1, 2024 | Sunday | News
Australia designs world first wearable device to record impact of artificial light for sound sleep

In a world first, a new wearable device developed by Australia's Monash University researchers will help to record the i...

August 25, 2024 | Sunday | News
Singapore approves GSK's Jemperli plus chemotherapy as first frontline immuno-oncology treatment

GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...

August 8, 2024 | Thursday | News
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

August 7, 2024 | Wednesday | News